A Randomized, Double-Blind, Vehicle-controlled, Parallel Group, Dose-Ranging, Multi-center Study of the Efficacy and Safety of Nexagon in the Treatment of Participants With Venous Leg Ulcers

Trial Profile

A Randomized, Double-Blind, Vehicle-controlled, Parallel Group, Dose-Ranging, Multi-center Study of the Efficacy and Safety of Nexagon in the Treatment of Participants With Venous Leg Ulcers

Completed
Phase of Trial: Phase II

Latest Information Update: 08 Dec 2014

At a glance

  • Drugs CODA 001 (Primary)
  • Indications Leg ulcer
  • Focus Therapeutic Use
  • Acronyms NOVEL
  • Sponsors CoDa Therapeutics Inc
  • Most Recent Events

    • 08 Dec 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top